Prevalence and timing of TP53 mutations in del(17p) myeloma and effect on survival

被引:45
作者
Chin, M. [1 ]
Sive, J. I. [2 ]
Allen, C. [1 ]
Roddie, C. [1 ]
Chavda, S. J. [1 ]
Smith, D. [1 ]
Blombery, P. [3 ]
Jones, K. [3 ]
Ryland, G. L. [3 ]
Popat, R. [1 ]
Rismani, A. [4 ]
D'Sa, S. [4 ]
Rabin, N. [4 ]
Gale, R. E. [1 ]
Yong, K. L. [1 ]
机构
[1] UCL, Canc Inst, Dept Haematol, London, England
[2] St Bartholomews Hosp, Dept Haematooncol, London, England
[3] Peter MacCallum Canc Ctr, Dept Pathol, Melbourne, Vic, Australia
[4] UCLH, Dept Haematol, London, England
关键词
MULTIPLE-MYELOMA; ABNORMALITIES; PROGNOSIS; SPECTRUM; THERAPY; COHORT; GENES;
D O I
10.1038/bcj.2017.76
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:e610 / e610
页数:4
相关论文
共 14 条
[1]   Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du Myelome [J].
Avet-Loiseau, Herve ;
Attal, Michel ;
Moreau, Philippe ;
Charbonnel, Catherine ;
Garban, Frederic ;
Hulin, Cyrille ;
Leyvraz, Serge ;
Michallet, Mauricette ;
Yakoub-Agha, Ibrahim ;
Garderet, Laurent ;
Marit, Gerald ;
Michaux, Lucienne ;
Voillat, Laurent ;
Renaud, Marc ;
Grosbois, Bernard ;
Guillerm, Gaelle ;
Benboubker, Lotfi ;
Monconduit, Mathieu ;
Thieblemont, Catherine ;
Casassus, Philippe ;
Caillot, Denis ;
Stoppa, Anne-Marie ;
Sotto, Jean-Jacques ;
Wetterwald, Marc ;
Dumontet, Charles ;
Fuzibet, Jean-Gabriel ;
Azais, Isabelle ;
Dorvaux, Veronique ;
Zandecki, Marc ;
Bataille, Regis ;
Minvielle, Stephane ;
Harousseau, Jean-Luc ;
Facon, Thierry ;
Mathiot, Claire .
BLOOD, 2007, 109 (08) :3489-3495
[2]   Improving overall survival and overcoming adverse prognosis in the treatment of cytogenetically high-risk multiple myeloma [J].
Bergsagel, P. Leif ;
Mateos, Maria-Victoria ;
Gutierrez, Norma C. ;
Rajkumar, S. Vincent ;
Miguel, Jesus F. San .
BLOOD, 2013, 121 (06) :884-892
[3]   The Clinical Impact and Molecular Biology of del(17p) in Multiple Myeloma Treated with Conventional or Thalidomide-Based Therapy [J].
Boyd, Kevin D. ;
Ross, Fiona M. ;
Tapper, William J. ;
Chiecchio, Laura ;
Dagrada, GianPaolo ;
Konn, Zoe J. ;
Gonzalez, David ;
Walker, Brian A. ;
Hockley, Sarah L. ;
Wardell, Christopher P. ;
Gregory, Walter M. ;
Child, J. Anthony ;
Jackson, Graham H. ;
Davies, Faith E. ;
Morgan, Gareth J. .
GENES CHROMOSOMES & CANCER, 2011, 50 (10) :765-774
[4]   Clinical significance of TP53 mutation in myeloma [J].
Chng, W. J. ;
Price-Troska, T. ;
Gonzalez-Paz, N. ;
Van Wier, S. ;
Jacobus, S. ;
Blood, E. ;
Henderson, K. ;
Oken, M. ;
Van Ness, B. ;
Greipp, P. ;
Rajkumar, S. V. ;
Fonseca, R. .
LEUKEMIA, 2007, 21 (03) :582-584
[5]   Targeted sequencing using a 47 gene multiple myeloma mutation panel (M3P) in-17p high risk disease [J].
Kortuem, Klaus M. ;
Langer, Christian ;
Monge, Jorge ;
Bruins, Laura ;
Egan, Jan B. ;
Zhu, Yuan X. ;
Shi, Chang Xin ;
Jedlowski, Patrick ;
Schmidt, Jessica ;
Ojha, Juhi ;
Bullinger, Lars ;
Liebisch, Peter ;
Kull, Miriam ;
Champion, Mia D. ;
Van Wier, Scott ;
Ahmann, Gregory ;
Rasche, Leo ;
Knop, Stefan ;
Fonseca, Rafael ;
Einsele, Hermann ;
Stewart, A. Keith ;
Braggio, Esteban .
BRITISH JOURNAL OF HAEMATOLOGY, 2015, 168 (04) :507-510
[6]   Targeted sequencing of refractory myeloma reveals a high incidence of mutations in CRBN and Ras pathway genes [J].
Kortum, K. Martin ;
Mai, Elias K. ;
Hanafiah, Nur H. ;
Shi, Chang-Xi ;
Zhu, Yuan-Xiao ;
Bruins, Laura ;
Barrio, Santiago ;
Jedlowski, Patrick ;
Merz, Maximilian ;
Xu, Jing ;
Stewart, Robert A. ;
Andrulis, Mindaugas ;
Jauch, Anna ;
Hillengass, Jens ;
Goldschmidt, Hartmut ;
Bergsagel, P. Leif ;
Braggio, Esteban ;
Stewart, A. Keith ;
Raab, Marc S. .
BLOOD, 2016, 128 (09) :1226-1233
[7]   Molecular spectrum of TP53 mutations in plasma cell dyscrasias by next generation sequencing: an italian cohort study and overview of the literature [J].
Lionetti, Marta ;
Barbieri, Marzia ;
Manzoni, Martina ;
Fabris, Sonia ;
Bandini, Cecilia ;
Todoerti, Katia ;
Nozza, Filomena ;
Rossi, Davide ;
Musto, Pellegrino ;
Baldini, Luca ;
Neri, Antonino .
ONCOTARGET, 2016, 7 (16) :21353-21361
[8]   Mutations in TP53 are exclusively associated with del(17p) in multiple myeloma [J].
Lode, Laurence ;
Eveillard, Marion ;
Trichet, Valerie ;
Soussi, Thierry ;
Wuilleme, Soraya ;
Richebourg, Steven ;
Magrangeas, Florence ;
Ifrah, Norbert ;
Campion, Loic ;
Traulle, Catherine ;
Guilhot, Francois ;
Caillot, Denis ;
Marit, Gerald ;
Mathiot, Claire ;
Facon, Thierry ;
Attal, Michel ;
Harousseau, Jean-Luc ;
Moreau, Philippe ;
Minvielle, Stephane ;
Avet-Loiseau, Herve .
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (11) :1973-1976
[9]   RETRACTED: Downregulation of p53-inducible microRNAs 192, 194, and 215 Impairs the p53/MDM2 Autoregulatory Loop in Multiple Myeloma Development (Retracted article. See vol. 40, pg. 1442, 2022) [J].
Pichiorri, Flavia ;
Suh, Sung-Suk ;
Rocci, Alberto ;
De Luca, Luciana ;
Taccioli, Cristian ;
Santhanam, Ramasamy ;
Zhou, Wenchao ;
Benson, Don M., Jr. ;
Hofmainster, Craig ;
Alder, Hansjuerg ;
Garofalo, Michela ;
Di Leva, Gianpiero ;
Volinia, Stefano ;
Lin, Huey-Jen ;
Perrotti, Danilo ;
Kuehl, Michael ;
Aqeilan, Rami I. ;
Palumbo, Antonio ;
Croce, Carlo M. .
CANCER CELL, 2010, 18 (04) :367-381
[10]   Cohort analysis of FISH testing of CD138+ cells in relapsed multiple myeloma: implications for prognosis and choice of therapy [J].
Smith, Dean ;
Stephenson, Clemency ;
Percy, Laura ;
Lach, Anna ;
Chatters, Steve ;
Kempski, Helena ;
Yong, Kwee .
BRITISH JOURNAL OF HAEMATOLOGY, 2015, 171 (05) :881-883